Thrasos

About:

Thrasos discovers and develops targeted therapies for the prevention and treatment of severe organ failures.

Website: http://www.thrasos.com

Top Investors: Fonds de solidarité FTQ, Lumira Ventures, SR One, GSK, Advanced Technology Ventures

Description:

Thrasos is a bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ failure, with a principle focus on kidney disease. The Company's lead therapeutic program, THR-184, is focused on the prevention and treatment of acute kidney injury (AKI). The Company also has a preclinical development program for treating chronic kidney disease (CKD).